Results 1 to 10 of about 132,090,430 (342)

Type 1 diabetes.

open access: yesThe Lancet, 2023
Type 1 diabetes is a chronic disease caused by autoimmune destruction of pancreatic β cells. Individuals with type 1 diabetes are reliant on insulin for survival.
Teresa Quattrin   +2 more
semanticscholar   +4 more sources

Differences in lipid and blood pressure measurements between individuals with type 1 diabetes and the general population: a cross-sectional study

open access: yesBMJ Open, 2023
Objectives Cardiovascular disease (CVD) is a precarious complication of type 1 diabetes (T1D). Alongside glycaemic control, lipid and blood pressure (BP) management are essential for the prevention of CVD.
Bruce H R Wolffenbuttel   +4 more
doaj   +1 more source

Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017.

open access: yesJournal of the American Medical Association (JAMA), 2021
Importance Changes in the prevalence of youth-onset diabetes have previously been observed. Objective To estimate changes in prevalence of type 1 and type 2 diabetes in youths in the US from 2001 to 2017.
J. Lawrence   +12 more
semanticscholar   +1 more source

Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis

open access: yesHealth Promotion Perspectives, 2020
Background: Diabetes is referred to a group of diseases characterized by high glucose levels in blood. It is caused by a deficiency in the production or function of insulin or both, which can occur because of different reasons, resulting in protein and ...
M. Mobasseri   +5 more
semanticscholar   +1 more source

RESEARCH INVOLVING HUMAN SUBJECTS IN UKRAINE: HOW TO LEVERAGE ARISING OPPORTUNITIES?

open access: yesProceedings of the Shevchenko Scientific Society: Medical Sciences, 2021
The review of the applications for grants of the National Research Foundation of Ukraine revealed evidence that many applicants-clinicians are not aware of the principles of Good Clinical Practice (GCP) that are implemented in different forms in the ...
Andriy Cherkas
doaj   +1 more source

Cardiovascular outcomes in type 1 and type 2 diabetes

open access: yesDiabetologia, 2023
Diabetes is one of the most prevalent cardiometabolic disorders on the planet. Type 1 diabetes accounts for only a minority of all cases (recently estimated to be ~2% globally); however, since this is a disorder with an early onset, many people live with
A. Rosengren, P. Dikaiou
semanticscholar   +1 more source

Beta cell and immune cell interactions in autoimmune type 1 diabetes: How they meet and talk to each other

open access: yesMolecular Metabolism, 2022
Background: The highly complex pathogenesis of Type 1 Diabetes is driven by several immune cell types with both effector and regulatory characteristics, which ultimately ends in the destruction of the insulin-producing beta cells.
Martin G. Scherm   +5 more
doaj   +1 more source

Global estimates of incidence of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Atlas, 10th Edition.

open access: yesDiabetes Research and Clinical Practice, 2021
BACKGROUND Type 1 diabetes (T1D) incidence in children and adolescents varies widely, and is increasing in many nations. The 10th edition of the International Diabetes Federation Atlas estimated incident cases in 2021 for 215 countries/territories ...
G. Ogle   +7 more
semanticscholar   +1 more source

Plasma Exosome-Enriched Extracellular Vesicles From Lactating Mothers With Type 1 Diabetes Contain Aberrant Levels of miRNAs During the Postpartum Period

open access: yesFrontiers in Immunology, 2021
Type 1 diabetes is an immune-driven disease, where the insulin-producing beta cells from the pancreatic islets of Langerhans becomes target of immune-mediated destruction.
Caroline Frørup   +22 more
doaj   +1 more source

The emerging role of lncRNAs in inflammatory bowel disease

open access: yesExperimental and Molecular Medicine, 2018
Inflammatory bowel disease: The role of noncoding RNA Studying long noncoding RNAs (lncRNAs) may improve diagnosis and treatment of inflammatory bowel disease (IBD).
Reza Yarani   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy